Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedAug 22, 2026
DataAggregated Company Financials
Companies20
  • 7D2.0%
  • 3M5.4%
  • 1Y-14.0%
  • YTD-7.7%

In the last week, the Healthcare industry is flat overall, with Demant standing out by going down 3.8%. As for the longer term, the industry has declined 14% in the last year. Earnings are forecast to grow by 4.7% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Aug 2026DKK 1.8tDKK 467.6bDKK 136.8b23.3x13.1x3.8x
Mon, 20 Jul 2026DKK 1.9tDKK 469.2bDKK 147.1b20.8x12.9x4.1x
Wed, 17 Jun 2026DKK 1.6tDKK 468.7bDKK 147.0b19.5x11.2x3.5x
Fri, 15 May 2026DKK 1.7tDKK 468.5bDKK 147.0b20.4x11.9x3.7x
Sun, 12 Apr 2026DKK 1.5tDKK 447.3bDKK 129.9b17.9x11.4x3.3x
Tue, 10 Mar 2026DKK 1.5tDKK 448.2bDKK 131.1b17.1x11.8x3.4x
Thu, 05 Feb 2026DKK 1.8tDKK 447.6bDKK 135.2b17.3x13.5x4.1x
Sat, 03 Jan 2026DKK 2.0tDKK 453.8bDKK 136.9b17x14.3x4.3x
Mon, 01 Dec 2025DKK 1.9tDKK 454.1bDKK 137.0b17.5x14x4.2x
Wed, 29 Oct 2025DKK 2.0tDKK 447.7bDKK 141.8b18.1x13.9x4.4x
Fri, 26 Sep 2025DKK 2.1tDKK 447.5bDKK 141.7b18.1x14.7x4.7x
Sun, 24 Aug 2025DKK 2.1tDKK 447.3bDKK 141.7b24.9x14.8x4.7x
Tue, 22 Jul 2025DKK 2.3tDKK 423.1bDKK 124.5b29.7x18.4x5.4x
Thu, 19 Jun 2025DKK 2.6tDKK 423.6bDKK 124.6b30.4x20.9x6.1x
Sat, 17 May 2025DKK 2.4tDKK 424.4bDKK 125.1b23.5x18.8x5.5x
Mon, 14 Apr 2025DKK 2.3tDKK 409.3bDKK 121.3b21.9x19x5.6x
Wed, 12 Mar 2025DKK 2.8tDKK 409.5bDKK 121.3b25.1x23.4x6.9x
Fri, 07 Feb 2025DKK 3.4tDKK 408.2bDKK 118.3b28.3x28.3x8.2x
Sun, 05 Jan 2025DKK 3.4tDKK 387.5bDKK 111.3b30.3x30.3x8.7x
Tue, 03 Dec 2024DKK 4.0tDKK 387.4bDKK 111.3b31.5x36x10.3x
Thu, 31 Oct 2024DKK 4.0tDKK 372.2bDKK 107.2b33.6x37.2x10.7x
Sat, 28 Sep 2024DKK 4.1tDKK 371.9bDKK 107.1b36.5x38.4x11.1x
Mon, 26 Aug 2024DKK 4.7tDKK 371.6bDKK 107.0b36.6x43.6x12.6x
Wed, 24 Jul 2024DKK 4.7tDKK 355.3bDKK 106.2b36.6x44.1x13.2x
Fri, 21 Jun 2024DKK 5.0tDKK 355.3bDKK 106.2b34.6x46.9x14x
Sun, 19 May 2024DKK 4.6tDKK 355.3bDKK 106.2b37.8x43.2x12.9x
Tue, 16 Apr 2024DKK 4.5tDKK 341.3bDKK 99.7b33.8x45.1x13.2x
Thu, 14 Mar 2024DKK 4.7tDKK 341.2bDKK 99.6b39.7x46.7x13.6x
Sat, 10 Feb 2024DKK 4.3tDKK 340.0bDKK 98.5b33.1x43.4x12.6x
Mon, 08 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b33.2x41.7x11.7x
Wed, 06 Dec 2023DKK 3.6tDKK 320.5bDKK 90.0b33.4x39.7x11.2x
Fri, 03 Nov 2023DKK 3.7tDKK 318.8bDKK 90.3b28.5x40.5x11.5x
Sun, 01 Oct 2023DKK 3.4tDKK 305.5bDKK 82.2b33.6x41.4x11.1x
Tue, 29 Aug 2023DKK 3.4tDKK 305.2bDKK 82.1b35.8x41.8x11.2x
Price to Earnings Ratio

41.8x


Total Market Cap: DKK 3.4tTotal Earnings: DKK 82.1bTotal Revenue: DKK 305.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 28x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.8x which is lower than its 3-year average PE of 28.0x.
  • The 3-year average PS ratio of 8.2x is higher than the industry's current PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 19% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.74%
Healthcare2.02%
Biotech5.83%
Healthtech5.75%
Life Sciences5.29%
Pharma1.81%
Medical Equipment0.14%
Healthcare Services-0.33%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 32.8x.
    • Analysts are expecting annual earnings growth of 18.2%, which is higher than its past year's earnings growth of 9.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 113% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings growth to stay flat over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 300.852.1%
+DKK 27.2b		-17.3%PE11.4x
GMAB GenmabDKK 2.15k6.1%
+DKK 7.4b		37.0%PE25.5x
COLO B ColoplastDKK 438.602.4%
+DKK 2.2b		-28.8%PE35.7x
BAVA Bavarian NordicDKK 209.4012.6%
+DKK 1.8b		-12.3%PE13.6x
CHEMM ChemoMetecDKK 487.405.2%
+DKK 421.1m		-7.4%PE47.9x

Latest News

HLUN B
DKK 41.04
H. Lundbeck
7D
-3.5%
1Y
2.9%
Analysis Article • 4h

H. Lundbeck A/S (CPH:HLUN B) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

A week ago, H. Lundbeck A/S ( CPH:HLUN B ) came out with a strong set of second-quarter numbers that could potentially...
ALK B
DKK 216.00
ALK-Abelló
7D
-1.2%
1Y
3.3%
BAVA
DKK 209.40
Bavarian Nordic
7D
12.6%
1Y
-12.3%
COLO B
DKK 438.60
Coloplast
7D
2.4%
1Y
-28.8%
Analysis Article • Aug 21

Coloplast A/S Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

The quarterly results for Coloplast A/S ( CPH:COLO B ) were released last week, making it a good time to revisit its...
GUBRA
DKK 391.80
Gubra
7D
5.4%
1Y
5.0%
DEMANT
DKK 287.00
Demant
7D
-3.5%
1Y
11.8%
Narrative Update • Aug 18

DEMANT: Updated Growth Outlook And Hearcare Expansion Will Support Further Upside

Demant's analyst price target has been updated from DKK 310 to DKK 345, reflecting a combination of recent target hikes into the DKK 296 to DKK 325 range and more cautious views from some analysts who cite valuation constraints. Analyst Commentary Recent research on Demant shows a split between more optimistic views and cautious stances, with several bullish analysts lifting price targets into the upper DKK 200s and low DKK 300s, while others flag valuation as a constraint.
AMBU B
DKK 76.80
Ambu
7D
0.3%
1Y
-24.6%
Narrative Update • Aug 15

AMBU B: Rising Competitive Pressure Will Drive More Cautious Share Performance

Analysts have raised their fair value estimate for Ambu to DKK 61 from DKK 58, while also reflecting slightly different assumptions for growth, margins and future P/E following recent research that highlights rising competitive pressure and a more cautious near term outlook. What’s in the News for Ambu Analysts revised their fair value estimate for Ambu to DKK 61 from DKK 58, reflecting updated assumptions on growth, margins and future P/E.
CHEMM
DKK 487.40
ChemoMetec
7D
5.2%
1Y
-7.4%
NOVO B
DKK 300.85
Novo Nordisk
7D
2.1%
1Y
-17.3%
Narrative Update • Aug 10

NOVO: From Hypergrowth to Execution Mode

10.08.2026 New CEO Mike Doustdar: His strength lies less in building factories and more in building markets. From my perspective, the share price has been driven by a lot of exaggeration.
GMAB
DKK 2,151.00
Genmab
7D
6.1%
1Y
37.0%
Analysis Article • Aug 09

Genmab A/S Just Beat EPS By 29%: Here's What Analysts Think Will Happen Next

It's been a good week for Genmab A/S ( CPH:GMAB ) shareholders, because the company has just released its latest...
EMBLA
DKK 30.00
Embla Medical hf
7D
0.5%
1Y
-6.3%
Analysis Article • Jul 24

Embla Medical hf. Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next

Embla Medical hf. ( CPH:EMBLA ) last week reported its latest second-quarter results, which makes it a good time for...
SMSMED
DKK 2.98
Scandinavian Medical Solutions
7D
-0.3%
1Y
-30.2%
STRAP
DKK 700.00
Strategic Partners
7D
-6.0%
1Y
-30.0%